Total Funding
45
35
Total FundingPost-IPO Equity raised
Growth Score
-9 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
43048
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Daniel Lynch: Executive ChairmanPast Role: Third Rock Ventures, Entrepreneur in Residence
James (Jim) Cassidy: Chief Medical Officer
About the Company
SpringWorks Therapeutics focuses on developing and commercializing innovative therapies for cancer treatment. The company specializes in targeted oncology, aiming to provide solutions that address unmet medical needs in the oncology space. SpringWorks offers a range of therapies, including those that target specific genetic mutations in tumors.
Their research emphasizes precision medicine, utilizing advanced methodologies to enhance treatment efficacy. The company engages in collaborations to accelerate the development of its pipeline and improve patient outcomes in oncology.
Women Founded
